Current Drug Targets-CNS & Neurological Disorders

Volume 1, Number 2, April 2002

Links for this Journal

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002
• Ingenta Connect ISSN
• Open URL

Book Reviews

Preface
pp. i-i(1)
Authors: Tamminga C.A.; Coyle J.T.

Links for this article

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002/art00001
• http://openurl.ingenta.com/content?genre=article&issn=1568-007X&volume=1&issue=2&spage=i&epage=i
• http://dx.doi.org/10.2174/1568007024606186

Reviews

Current Status of Antipsychotic Treatment
pp. 123-128(6)
Authors: Conley R.R.; Kelly D.L.

Links for this article

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002/art00002
• http://openurl.ingenta.com/content?genre=article&issn=1568-007X&volume=1&issue=2&spage=123&epage=128
• http://dx.doi.org/10.2174/1568007024606221

Treatment of Schizophrenia and Comorbid Substance Use Disorder
pp. 129-139(11)
Authors: Green A.I.; Salomon M.S.; Brenner M.J.; Rawlins K.

Links for this article

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002/art00003
• http://openurl.ingenta.com/content?genre=article&issn=1568-007X&volume=1&issue=2&spage=129&epage=139
• http://dx.doi.org/10.2174/1568007024606230

Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
pp. 141-147(7)
Authors: Tamminga C.A.; Carlsson A.

Links for this article

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002/art00004
• http://openurl.ingenta.com/content?genre=article&issn=1568-007X&volume=1&issue=2&spage=141&epage=147
• http://dx.doi.org/10.2174/1568007024606195

Nicotinic Agonists and Psychosis
pp. 149-162(14)
Authors: Simosky J.K.; Stevens K.E.; Freedman R.

Links for this article

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002/art00005
• http://openurl.ingenta.com/content?genre=article&issn=1568-007X&volume=1&issue=2&spage=149&epage=162
• http://dx.doi.org/10.2174/1568007024606168

Muscarinic Receptors as a Target for Drugs Treating Schizophrenia
pp. 163-181(19)
Authors: Bymaster F.P.; Felder C.; Ahmed S.; McKinzie D.

Links for this article

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002/art00006
• http://openurl.ingenta.com/content?genre=article&issn=1568-007X&volume=1&issue=2&spage=163&epage=181
• http://dx.doi.org/10.2174/1568007024606249

Ionotropic Glutamate Receptors as Therapeutic Targets in Schizophrenia
pp. 183-189(7)
Authors: Coyle J.T.; Tsai G.; Goff D.C.

Links for this article

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002/art00007
• http://openurl.ingenta.com/content?genre=article&issn=1568-007X&volume=1&issue=2&spage=183&epage=189
• http://dx.doi.org/10.2174/1568007024606212

N-Methyl-D-Aspartate Receptor-Coupled GlycineB Receptors in the Pathogenesis and Treatment of Schizophrenia: A Critical Review
pp. 191-213(23)
Author: Millan M.J.

Links for this article

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002/art00008
• http://openurl.ingenta.com/content?genre=article&issn=1568-007X&volume=1&issue=2&spage=191&epage=213
• http://dx.doi.org/10.2174/1568007024606258

Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?
pp. 215-225(11)
Authors: Schoepp D.D.; Marek G.J.

Links for this article

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002/art00009
• http://openurl.ingenta.com/content?genre=article&issn=1568-007X&volume=1&issue=2&spage=215&epage=225
• http://dx.doi.org/10.2174/1568007024606177

Novel Directions in Antipsychotic Target Identification using Gene Arrays
pp. 227-238(12)
Authors: Palfreyman M.G.; Hook D.J.; Klimczak L.J.; Brockman J.A.; Evans D.M.; Altar C.Anthony

Links for this article

• http://www.ingentaconnect.com/content/ben/cdtcnsnd/2002/00000001/00000002/art00010
• http://openurl.ingenta.com/content?genre=article&issn=1568-007X&volume=1&issue=2&spage=227&epage=238
• http://dx.doi.org/10.2174/1568007024606203